PDRN CareTransforming Growth Factor-Beta (TGF-β)
Dr. Sarah Chen
PhD, Molecular Biology
Transforming growth factor-beta (TGF-beta) is a superfamily of multifunctional cytokines that regulate cell growth, differentiation, extracellular matrix production, and immune responses across virtually every tissue in the body [1].
Definition
Transforming growth factor-beta (TGF-beta) is a superfamily of multifunctional cytokines that regulate cell growth, differentiation, extracellular matrix production, and immune responses across virtually every tissue in the body [1]. In skin biology, TGF-beta is the master regulator of collagen synthesis by dermal fibroblasts and plays a central role in all phases of wound healing [1][3]. The three mammalian TGF-beta isoforms — TGF-beta1, TGF-beta2, and TGF-beta3 — have overlapping yet distinct functions in dermal homeostasis and repair [3].
TGF-β Signaling Pathway
Canonical Smad Signaling
TGF-beta signals through a well-characterized receptor-mediated pathway [1]. The ligand binds to the TGF-beta type II receptor (TbetaRII), which recruits and phosphorylates the type I receptor (TbetaRI/ALK5). The activated type I receptor then phosphorylates Smad2 and Smad3 proteins, which form a complex with the co-mediator Smad4 [1]. This Smad complex translocates to the nucleus, where it activates transcription of target genes — most critically, the genes encoding type I and type III procollagen, the primary structural proteins of the dermis [1][2].
Non-Canonical Pathways
TGF-beta also activates Smad-independent pathways including MAPK, PI3K/Akt, and Rho GTPase signaling [1]. These pathways regulate cell migration, cytoskeletal dynamics, and matrix metalloproteinase expression, contributing to the context-dependent nature of TGF-beta's effects.
TGF-β in Skin Health and Aging
Collagen Homeostasis
In healthy adult skin, TGF-beta signaling through the Smad pathway maintains ongoing collagen production by dermal fibroblasts [2]. This constitutive signaling is essential for replacing the approximately 3 to 5 percent of dermal collagen that is turned over annually through normal matrix metalloproteinase activity.
UV-Induced TGF-β Suppression
Ultraviolet radiation disrupts TGF-beta signaling at multiple levels [2]. UV exposure activates AP-1, a transcription factor that interferes with Smad-dependent gene transcription. UV also reduces expression of TbetaRII on the fibroblast surface, making cells less responsive to TGF-beta stimulation [2]. The combined effect is a significant reduction in new collagen synthesis — studies show that a single UV exposure can suppress procollagen production by up to 80 percent for 24 hours [2]. Chronic UV exposure leads to sustained TGF-beta signaling impairment, which is a primary mechanism of photoaging-related collagen loss.
TGF-β in Wound Healing
TGF-beta orchestrates wound repair across all healing phases [3]:
- Inflammation — TGF-beta1 recruits monocytes and macrophages to the wound site and modulates their activation state [3]
- Proliferation — TGF-beta stimulates fibroblast migration into the wound bed, promotes their differentiation into myofibroblasts (which contract the wound), and drives collagen and fibronectin deposition [3]
- Remodeling — TGF-beta regulates the balance between new collagen synthesis and MMP-mediated matrix turnover during scar maturation [3]
Notably, the ratio of TGF-beta isoforms influences scarring outcomes. TGF-beta1 and TGF-beta2 promote scar formation, while TGF-beta3 is associated with reduced scarring — fetal wounds, which heal without scars, have elevated TGF-beta3 relative to TGF-beta1 [3].
PDRN and TGF-β Signaling
PDRN interacts with TGF-beta-mediated processes through several mechanisms [4][5]:
Enhanced Collagen Synthesis
PDRN stimulates fibroblast collagen production through A2A receptor activation, which upregulates growth factor expression including TGF-beta [4][5]. By increasing TGF-beta signaling in fibroblasts, PDRN amplifies the canonical Smad pathway that drives procollagen transcription. This effect is particularly valuable in photoaged skin where UV-induced TGF-beta pathway suppression has reduced baseline collagen synthesis.
Anti-Inflammatory Modulation
Excessive TGF-beta signaling drives pathological fibrosis and hypertrophic scarring [3]. PDRN's anti-inflammatory action through A2A receptor activation helps maintain TGF-beta signaling within a physiological range [4]. By suppressing pro-inflammatory cytokines that amplify TGF-beta1 production, PDRN promotes balanced healing rather than excessive scar formation.
Nucleotide Supply for Matrix Production
The massive collagen synthesis driven by TGF-beta signaling requires correspondingly high rates of protein translation and cell division [4][5]. PDRN provides nucleotide substrates through the salvage pathway, supporting the DNA and RNA synthesis necessary for fibroblasts responding to TGF-beta stimulation to proliferate and produce extracellular matrix.
Clinical Relevance
TGF-beta biology informs several aspects of PDRN clinical use [4][5]:
- Post-UV recovery — PDRN helps restore TGF-beta-mediated collagen synthesis that UV exposure has suppressed
- Scar management — PDRN's balanced modulation of inflammation and TGF-beta signaling supports organized collagen deposition rather than hypertrophic scarring
- Combination protocols — PDRN paired with retinoids (which also upregulate TGF-beta signaling) may produce synergistic collagen-stimulating effects
References
- [1]Massague J. TGFbeta signalling in context. Nat Rev Mol Cell Biol. 2012;13(10):616-630. doi:10.1038/nrm3434
- [2]Quan T, He T, Kang S, Voorhees JJ, Fisher GJ. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling. Am J Pathol. 2004;165(3):741-751. doi:10.1016/S0002-9440(10)63337-8
- [3]Penn JW, Grobbelaar AO, Rolfe KJ. The role of the TGF-beta family in wound healing, burns and scarring: a review. Int J Burns Trauma. 2012;2(1):18-28.
- [4]Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Curr Pharm Des. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
- [5]Colangelo MT, Galli C, Gentile P. Polydeoxyribonucleotide: A Promising Biological Platform for Dermal Regeneration. Curr Pharm Des. 2020;26(17):2049-2056.